Skip to content

The Hanover Insurance

US · THG #1711 by market cap Listed 1970
243.19 +0.20 +0.08%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 21 in the most recent period (2026/Q3).
  • Total institutional ownership rose 1.6 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
94.10% +1.58pp
Institutions
642 +21
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund78.54%
Hedge Fund7.45%
Public Company2.91%
Government Pension Fund1.71%
Sovereign Wealth Fund1.30%
Insurance Company0.99%
Individual/Insider0.96%
Private Company0.69%
Family Office/Trust0.30%
Other5.13%

Top holders as of 2026-09-30

BlackRock 10.09% · 3.47M sh
Vanguard Portfolio Management, LLC 5.64% · 1.94M sh
T. Rowe Price Group, Inc. 5.58% · 1.92M sh
State Street Global Advisors 4.67% · 1.60M sh
Vanguard Capital Management, LLC 4.23% · 1.45M sh
AQR Capital Management 3.88% · 1.33M sh
Dimensional Fund Advisors 3.26% · 1.12M sh
Fuller & Thaler Asset Management, Inc. 3.17% · 1.09M sh
American Century Investment Management 2.85% · 979.19K sh
AllianceBernstein 2.64% · 909.13K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 37 buys · 13 sells

NameRoleStake
John Roche Chief Executive Officer 0.37%
Jeffrey Farber Chief Financial Officer 0.17%
Joseph Ramrath Independent Director 0.10%
Richard Lavey Chief Operating Officer 0.08%
Bryan Salvatore Executive VP & President of Specialty 0.07%
Cynthia Egan Independent Chairperson & Independent Presiding Director 0.03%
Kevin Bradicich Independent Director 0.03%
Dennis Kerrigan Executive VP, Chief Legal Officer, Corporate Secretary & Interim Chief Human Resources Officer 0.02%
Willard Lee Executive VP and Chief Information & Innovation Officer 0.02%
James Condrin Independent Director 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-11 John Roche Chief Executive Officer Derivative Exercise and Sale -74,620 $104.11–250.00
2026-11-11 John Roche Chief Executive Officer Intent to Sell (Form 144) -14,422 $249.39
2026-11-10 John Roche Chief Executive Officer Derivative Exercise and Retained +9,971 $104.11
2026-11-03 Theodore Bunting Independent Director Other Disposition -450 --
2026-11-03 Willard Lee Executive VP and Chief Information & Innovation Officer Open Market Disposition -60 $249.69
2026-11-03 Willard Lee Executive VP and Chief Information & Innovation Officer Derivative Exercise and Sale -9,886 $115.35–249.69
2026-09-24 Joseph Ramrath Independent Director Other Acquisition +3 --
2026-09-24 Kathleen Lane Independent Director Other Acquisition +3 --
2026-09-24 Theodore Bunting Independent Director Other Acquisition +3 --
2026-09-24 Jeffrey Farber Chief Financial Officer Other Acquisition +41 --
2026-09-24 Richard Lavey Chief Operating Officer Other Acquisition +27 --
2026-09-24 William Donnell Independent Director Other Acquisition +3 --
2026-09-24 Elizabeth A. Chicares Independent Director Other Acquisition +3 --
2026-09-24 Cynthia Egan Independent Chairperson & Independent Presiding Director Other Acquisition +3 --
2026-09-24 John Roche Chief Executive Officer Other Acquisition +120 --
2026-09-24 Bryan Salvatore Executive VP & President of Specialty Other Acquisition +24 --
2026-09-24 Dennis Kerrigan Executive VP, Chief Legal Officer, Corporate Secretary & Interim Chief Human Resources Officer Other Acquisition +14 --
2026-09-24 James Condrin Independent Director Other Acquisition +3 --
2026-09-24 Francisco Aristeguieta Silva Independent Director Other Acquisition +3 --
2026-09-24 Jane Carlin Independent Director Other Acquisition +3 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

The Hanover Insurance discussion 0 comments

Add a comment